KENDALL WINES: Open Payments
NPI 1366729311 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 35 payments from 12 companies in 2025. Trend: 2023 $838 · 2024 $2,466 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $205 |
| Janssen Biotech, Inc. | 3 | $146 |
| Enterra Medical, Inc. | 1 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| QOL Medical, LLC | 2 | $79 |
| Aimmune Therapeutics, Inc. | 3 | $63 |
| Abbott Laboratories | 4 | $59 |
| Ardelyx, Inc. | 1 | $51 |
| Phathom Pharmaceuticals, Inc. | 4 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: TREMFYA, RINVOQ, Sucraid, CREON, ZENPEP, ULTREON, IBSRELA, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
